SCHEMBL23590378

SCHEMBL23590378

CCc1nc(N2CCOCC2)n[nH]1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 3/20 0.57
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ KMT2A Q03164 4/20 0.40
▸ MEN1 O00255 3/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ POLB P06746 2/20 0.40
▸ TSHR P16473 1/20 0.40
▸ TACR2 P21452 1/20 0.40
▸ NUDT1 P36639 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.38
▸ HTT P42858 1/20 0.38
▸ PIK3R1 P27986 1/20 0.38
▸ PIK3CA P42336 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ NPC1 O15118 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ CASP1 P29466 1/20 0.37
▸ STAT1 P42224 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21888966 0.77 GAA (0.62) GAASMN1; SMN2MAPK1KMT2AHSD17B10
SCHEMBL1994355 0.73 GAA (1.00) GAAALDH1A1HTTPIK3R1PIK3CA
SCHEMBL22761364 0.70 GAA (0.54) GAASMN1; SMN2MAPK1KMT2AHSD17B10
SCHEMBL22750817 0.69 GAA (0.62) GAASMN1; SMN2MAPK1HSD17B10POLB
SCHEMBL8973821 0.68 HTT (0.63) GAASMN1; SMN2MAPK1KMT2AMEN1
SCHEMBL2815267 0.67 MAPK1 (0.51) GAASMN1; SMN2MAPK1KMT2AMEN1
SCHEMBL9418611 0.66 HTT (0.61) GAASMN1; SMN2MAPK1KMT2AMEN1
SCHEMBL12110270 0.66 SMN1; SMN2 (0.50) SMN1; SMN2MAPK1KMT2AMEN1NUDT1
SCHEMBL15386251 0.64 MAPT (0.50) GAASMN1; SMN2MAPK1KMT2AMEN1
SCHEMBL17827961 0.64 PIK3CA (0.51) SMN1; SMN2MAPK1ALDH1A1PIK3R1PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210198220-A1 SSAO INHIBITOR SHANDONG DANHONG PHARMACEUTICAL CO LTD (CN) 2021-07-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210198220-A1 SSAO INHIBITOR SSB, ASAH2, AOX1 GAA 51/4885SMN1; SMN2 1539/4885MAPK1 3164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback